Johnson & Johnson earnings per share (EPS) for the twelve months ending Nov 11, 2024 was $6.1, a (55.3%) increase year-over-year.
As of Nov 11, 2024, Johnson & Johnson's P/E ratio is 25.7x. This is calculated by dividing the current share price of $155.0 by the Earnings per Share (EPS) for the trailing twelve months, which is $6.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $159.2, compared to a market price of around $155.0. This suggests a potential undervaluation of 2.7%.